Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Aquestive Therapeutics Inc (NASDAQ: AQST) closed at $2.29 down -19.65% from its previous closing price of $2.85. In other words, the price has decreased by -$19.65 from its previous closing price. On the day, 9.32 million shares were traded.
Ratios:
For a deeper understanding of Aquestive Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.48 and its Current Ratio is at 4.87.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on December 17, 2024, initiated with a Overweight rating and assigned the stock a target price of $17.
On May 10, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $8.
On April 11, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $10.Piper Sandler initiated its Overweight rating on April 11, 2024, with a $10 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 26 ’24 when Jung Cassie sold 44 shares for $4.87 per share. The transaction valued at 214 led to the insider holds 0 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.19.
Stock Price History:
Over the past 52 weeks, AQST has reached a high of $5.80, while it has fallen to a 52-week low of $2.20. The 50-Day Moving Average of the stock is -17.92%, while the 200-Day Moving Average is calculated to be -39.45%.
Shares Statistics:
A total of 99.32M shares are outstanding, with a floating share count of 87.98M. Insiders hold about 11.42% of the company’s shares, while institutions hold 37.98% stake in the company.
